Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LIPID-LOWERING THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Doggrell, SA
      Statins in the 21st century: end of the simple story?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Zhao, XQ; Yuan, C; Hatsukami, TS; Frechette, EH; Kang, XJ; Maravilla, KR; Brown, BG
      Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI - A case-control study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Cheng, JWM
      Recognition, pathophysiology, and management of acute myocardial infarction

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    4. Yokoyama, I; Yonekura, K; Inoue, Y; Ohtomo, K; Nagai, R
      Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance

      JOURNAL OF NUCLEAR CARDIOLOGY
    5. Schwartz, RG
      Beyond the cholesterol profile: Monitoring therapeutic effectiveness of statin therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    6. Deskur-Smielecka, E; Wykretowicz, A; Kempa, M; Furmaniuk, J; Wysocki, H
      The influence of short-term treatment with simvastatin on the inflammatoryprofile of patients with hypercholesterolaemia

      CORONARY ARTERY DISEASE
    7. Stein, EA
      Aggressive treatment of dyslipidemia: A review of supporting evidence

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    8. Stefanutti, C; Di Giacomo, S; Vivenzio, A; Colloridi, V; Bosco, G; Berni, A; Rabbone, I; Cerutti, F; Bertolini, S
      Low-density lipoprotein apheresis in a patient aged 3.5 years

      ACTA PAEDIATRICA
    9. Niemeijer-Kanters, SDJM; Banga, JD; Erkelens, DW
      Lipid-lowering therapy in diabetes mellitus

      NETHERLANDS JOURNAL OF MEDICINE
    10. Olson, KL; Bungard, TJ; Tsuyuki, RT
      Cholesterol risk management: A systematic examination of the gap from evidence to practice

      PHARMACOTHERAPY
    11. Hilleman, DE; Monaghan, MS; Ashby, CL; Mashni, JE; Woolley, K; Amato, CM
      Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease

      PHARMACOTHERAPY
    12. Davidson, MH; Toth, P; Weiss, S; McKenney, J; Hunninghake, D; Isaacsohn, J; Donovan, JM; Burke, SK
      Low-dose combination therapy with colesevelam hydrochloride and lovastatineffectively decreases low-density lipoprotein cholesterol in patients withprimary hypercholesterolemia

      CLINICAL CARDIOLOGY
    13. Tzivoni, D
      End organ protection by calcium-channel blockers

      CLINICAL CARDIOLOGY
    14. Moore, R; Hernandez, D; Valantine, H
      Calcineurin inhibitors and post-transplant hyperlipidaemias

      DRUG SAFETY
    15. Massy, ZA
      Hyperlipidemia and cardiovascular disease after organ transplantation

      TRANSPLANTATION
    16. Susekov, AV
      Validation of elevation of statins doses in clinical practice

      TERAPEVTICHESKII ARKHIV
    17. Insull, W; Toth, P; Mullican, W; Hunninghake, D; Burke, S; Donovan, JM; Davidson, MH
      Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial

      MAYO CLINIC PROCEEDINGS
    18. Zhdanova, IV; Barats, SS; Tsvirenko, SV; Smolenskaya, OG; Volkova, RF; Serezhenko, TO
      Effect of various lipid-lowering drugs on parameters of hemostasis and microcirculation during treatment of atherosclerosis

      KARDIOLOGIYA
    19. Kuroedov, AY; Nikolaeva, AA
      Effect of simvastatin on parameters of vascular reactivity in patients with hypertension and various baseline levels of blood lipids

      KARDIOLOGIYA
    20. Cucchiara, B; Kasner, SE
      Use of statins in CNS disorders

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    21. Niemeijer-Kanters, SDJM; Dallinga-Thie, GM; de Ruijter-Heijstek, FC; Algra, A; Erkelens, DW; Banga, JD; Jansen, H
      Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus

      ATHEROSCLEROSIS
    22. Malhotra, HS; Goa, KL
      Atorvastatin - An updated review of its pharmacological properties and usein dyslipidaemia

      DRUGS
    23. Castano, G; Mas, R; Fernandez, L; Illnait, J; Gamez, R; Fernandez, JC
      Comparison of two regimens of policosanol administered at 20 mg/d in patients with type II hypercholesterolemia: A randomized, double-blind, placebo-controlled study

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    24. Greenland, P; Smith, SC; Grundy, SM
      Improving coronary heart disease risk assessment in asymptomatic people - Role of traditional risk factors and noninvasive cardiovascular tests

      CIRCULATION
    25. Andrews, TC; Ballantyne, CM; Hsia, JA; Kramer, JH
      Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins

      AMERICAN JOURNAL OF MEDICINE
    26. Castelli, WP
      Making practical sense of clinical trial data in decreasing cardiovascularrisk

      AMERICAN JOURNAL OF CARDIOLOGY
    27. Brown, WV
      What are the priorities for managing cholesterol effectively?

      AMERICAN JOURNAL OF CARDIOLOGY
    28. Ansell, BJ
      Developing a clinical strategy for cholesterol management in an era of unanswered questions

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Sloan, KL; Sales, AE; Willems, JP; Every, NR; Martin, GV; Sun, HL; Pineros, S; Sharp, N
      Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results <= 100 mg/dl among patients who had coronary events (Northwest VA Network study)

      AMERICAN JOURNAL OF CARDIOLOGY
    30. Amoroso, G; Van Boven, AJ; Crijns, HJGM
      Drug therapy or coronary angioplasty for the treatment of coronary artery disease: New insights

      AMERICAN HEART JOURNAL
    31. Puddu, P; Puddu, GM; Muscari, A
      Current thinking in statin therapy

      ACTA CARDIOLOGICA
    32. Barter, PJ
      Treating to target with statins

      ATHEROSCLEROSIS SUPPLEMENTS
    33. Davidson, MH; Dicklin, MR; Maki, KC; Kleinpell, RM
      Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    34. Jackson, PR; Ramsay, LE
      Debate: at what level of coronary heart disease risk should a statin be prescribed?

      CURRENT OPINION IN LIPIDOLOGY
    35. Gaw, A; Packard, CJ
      At what level of coronary heart disease risk should a statin be prescribed?

      CURRENT OPINION IN LIPIDOLOGY
    36. Fodor, JG; Frohlich, JJ; Genest, JJG; McPherson, PR
      Recommendations for the management and treatment of dyslipidemia - Report of the Working Group on hypercholesterolemia and other dyslipidemias

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    37. Hilleman, DE; Heineman, SM; Foral, PA
      Pharmacoeconomic assessment of HMG-CoA reductase inhibitor therapy: An analysis based on the CURVES study

      PHARMACOTHERAPY
    38. Koh, KK
      Effects of HMG-CoA reductase inhibitor on hemostasis

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    39. Pearson, TA
      The undertreatment of LDL-cholesterol: addressing the challenge

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    40. Motulsky, AG; Beutler, E
      Population screening in hereditary hemochromatosis

      ANNUAL REVIEW OF PUBLIC HEALTH
    41. Marchesi, S; Lupattelli, G; Siepi, D; Schillaci, G; Vaudo, G; Roscini, AR; Sinzinger, H; Mannarino, E
      Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    42. Landmesser, U; Hornig, B; Drexler, H
      Endothelial dysfunction in hypercholesterolemia: Mechanisms, pathophysiological importance, and therapeutic interventions

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    43. Calmy, A; Lopez-Liuchi, JV; Borst, F; Meier, CA
      Comparison of current guidelines for the treatment of hypercholesterolaemia in secondary prevention: can the Swiss recommendations be simplified?

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    44. Ballantyne, CM
      Primary prevention of coronary heart disease

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    45. Ferguson, EE
      Preventing, stopping, or reversing coronary artery disease - Triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: The need for recognition and treatment

      DM DISEASE-A-MONTH
    46. Habib, G; Paillard, F; Charpentier, G; Angellier, JF; Roux, T; Portal, JJ; Maigret, P
      A multicenter, open-label, randomized study comparing the efficacy of atorvastatin versus usual care in reducing refractory hypercholesterolemia in high-risk patients to target levels

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    47. Maron, DJ; Fazio, S; Linton, MF
      Current perspectives on statins

      CIRCULATION
    48. Kroll, MH; Cole, TG; Rifai, N; Cooper, G; Warnick, GR; Jialal, I
      Standardization of lipoprotein reporting

      AJCP. American journal of clinical pathology
    49. Davignon, J; Laaksonen, R
      Low-density lipoprotein-independent effects of statins

      CURRENT OPINION IN LIPIDOLOGY
    50. Kario, K; Matsuo, T; Hoshide, S; Kobayashi, H; Sakata, T; Mizuno, O; Mitsuhashi, T; Ikeda, U; Miyata, T; Shimada, K
      Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients

      BLOOD COAGULATION & FIBRINOLYSIS
    51. Prichard, S
      Dyslipidemia as a risk factor for cardiac disease in dialysis patients

      SEMINARS IN DIALYSIS
    52. Warshafsky, S; Packard, D; Marks, SJ; Sachdeva, N; Terashita, DM; Kaufman, G; Song, K; Deluca, AJ; Peterson, SJ; Frishman, WH
      Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors forprevention of stroke

      JOURNAL OF GENERAL INTERNAL MEDICINE
    53. Rensing, UFE; Bestehorn, HP; Roskamm, H; Petersen, J; Betz, P; Spinder, M; Benesch, L; Schemeitat, K; Blumchen, G; Claus, J; Wieland, H; Bocker, JF; Neiss, A; Stiepel, E; Mathes, P; Kappenberger, L; Braunagel, K; Peters, K; Meister, G; Samek, L; Schuon, J; Leimenstoll, B; Kiefer, H
      Lipid intervention and coronary artery disease (CAD) in men below 56 yearsof age. The Coronary Intervention Study: CIS

      ZEITSCHRIFT FUR KARDIOLOGIE
    54. Berg, AL; Nilsson-Ehle, P; Arnadottir, M
      Beneficial effects of ACTH on the serum lipoprotein profile and glomerularfunction in patients with membranous nephropathy

      KIDNEY INTERNATIONAL
    55. Riegger, G; Abletshauser, C; Ludwig, M; Schwandt, P; Widimsky, J; Weidinger, G; Welzel, D
      The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

      ATHEROSCLEROSIS
    56. Yokoyama, I; Momomura, S; Ohtake, T; Yonekura, K; Yang, WD; Kobayakawa, N; Aoyagi, T; Sugiura, S; Yamada, N; Ohtomo, K; Sasaki, Y; Omata, M; Yazaki, Y
      Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy

      CIRCULATION
    57. Brier, KL; Tornow, JJ; Ries, AJ; Weber, MP; Downs, JR
      Forecasting patient outcomes in the management of hyperlipidemia

      ARCHIVES OF INTERNAL MEDICINE
    58. Davidson, MH; Dillon, MA; Gordon, B; Jones, P; Samuels, J; Weiss, S; Isaacsohn, J; Toth, P; Burke, SK
      Colesevelam hydrochloride (Cholestagel) - A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects

      ARCHIVES OF INTERNAL MEDICINE
    59. Brown, WV
      Impact of dyslipidaemia - Lessons from clinical trials

      PHARMACOECONOMICS
    60. YEE HS; FONG NT
      ATORVASTATIN IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIAS

      The Annals of pharmacotherapy
    61. LAMARCHE B; LEWIS GF
      ATHEROSCLEROSIS PREVENTION FOR THE NEXT DECADE - RISK ASSESSMENT BEYOND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL

      Canadian journal of cardiology
    62. ARROYO LH; LEE RT
      THE UNSTABLE ATHEROMATOUS PLAQUE

      Canadian journal of cardiology
    63. STUYT PMJ; KLEINJANS HAJ; STALENHOEF AFH
      TOLERABILITY AND EFFECTS OF HIGH-DOSES ACIPIMOX AS ADDITIONAL LIPID-LOWERING THERAPY IN FAMILIAL HYPERCHOLESTEROLEMIA

      Netherlands journal of medicine
    64. MCLAUGHLIN PR; GLADSTONE P
      DIABETES ATHEROSCLEROSIS INTERVENTION STUDY (DAIS) - QUANTITATIVE CORONARY ANGIOGRAPHIC ANALYSIS OF CORONARY-ARTERY ATHEROSCLEROSIS

      Catheterization and cardiovascular diagnosis
    65. KO GTC; MAK TWL; YEUNG VTF; CHAN DCF; LAM CWK; TSANG LWW; CHOW CC; COCKRAM CS
      SHORT-TERM EFFICACY AND TOLERABILITY OF COMBINATION THERAPY WITH LOVASTATIN AND ACIPIMOX IN CHINESE PATIENTS WITH TYPE-2 DIABETES-MELLITUS AND MIXED DYSLIPIDEMIA

      Journal of clinical pharmacology
    66. SHALAEV SV; ALMANOVA LI; MEDVEDEVA IV; SAFIULLINA ZM; KOZLOV AA; ZHURAVLEVA TD
      HYPOLIPIDEMIC PROPERTIES OF SOLUBLE DIETA RY-FIBERS (PECTIN) IN PATIENTS WITH ISCHEMIC-HEART-DISEASE

      Kardiologia
    67. BERGLUND L; WITZTUM JL; GALEANO NF; KHOUW AS; GINSBERG HN; RAMAKRISHNAN R
      3-FOLD EFFECT OF LOVASTATIN TREATMENT ON LOW-DENSITY-LIPOPROTEIN METABOLISM IN SUBJECTS WITH HYPERLIPIDEMIA - INCREASE IN RECEPTOR ACTIVITY, DECREASE IN APO-B PRODUCTION, AND DECREASE IN PARTICLE AFFINITY FOR THE RECEPTOR - RESULTS FROM A NOVEL TRIPLE-TRACER APPROACH

      Journal of lipid research
    68. PAPADAKIS JA; MIKHAILIDIS DP; WINDER AF
      LIPIDS AND STROKE - NEGLECT OF A USEFUL PREVENTIVE MEASURE

      Cardiovascular Research
    69. ZAFARI AM; WENGER NK
      SECONDARY PREVENTION OF CORONARY HEART-DISEASE

      Archives of physical medicine and rehabilitation
    70. BALLANTYNE CM
      LOW-DENSITY LIPOPROTEINS AND DISK FOR CORONARY-ARTERY DISEASE

      The American journal of cardiology
    71. BROWN BG; ZAMBON A; POULIN D; ROCHA A; MAHER VMG; DAVIS JW; ALBERS JJ; BRUNZELL JD
      USE OF NIACIN, STATINS, AND RESINS IN PATIENTS WITH COMBINED HYPERLIPIDEMIA

      The American journal of cardiology
    72. SHEPHERD J
      TOMORROWS WORLD - ATHEROSCLEROSIS IN THE YEAR 2000

      Netherlands journal of medicine
    73. CHONG PH; SEEGER JD
      ATORVASTATIN CALCIUM - AN ADDITION TO HMG-COA REDUCTASE INHIBITORS

      Pharmacotherapy
    74. RINDONE JP; ARRIOLA OG
      EXPERIENCE WITH CRYSTALLINE NIACIN AS THE PREFERRED DRUG FOR DYSLIPIDEMIA IN A SPECIALTY CLINIC

      Pharmacotherapy
    75. KONZEM SL; GRAY DR; KASHYAP ML
      EFFECT OF PHARMACEUTICAL CARE ON OPTIMUM COLESTIPOL TREATMENT IN ELDERLY HYPERCHOLESTEROLEMIC VETERANS

      Pharmacotherapy
    76. LEWIS B; WATTS GF
      PARADISE REGAINED - INSIGHTS INTO CORONARY HEART-DISEASE PREVENTION FROM RECENT CLINICAL-TRIALS AND BASIC RESEARCH

      Journal of the Royal College of Physicians of London
    77. SIMPSON IJ; BAILEY RR; ROBSON RA; PRICE M; COLLINS JF; LYNN KL
      MANAGEMENT GUIDELINES FOR PROGRESSIVE CHRONIC-RENAL-FAILURE

      New Zealand medical journal
    78. STROES E; DEBRUIN T; DEVALK H; ERKELENS W; BANGA JD; VANRIJN H; KOOMANS H; RABELINK T
      NO ACTIVITY IN FAMILIAL COMBINED HYPERLIPIDEMIA - POTENTIAL ROLE OF CHOLESTEROL REMNANTS

      Cardiovascular Research
    79. RAFFLENBEUL W
      ANTIATHEROSCLEROTIC PROPERTIES OF NIFEDIPINE - BENEFIT OF EARLY INTERVENTION TO PREVENT CARDIOVASCULAR COMPLICATIONS

      Cardiology
    80. FOUBERT L; DEJAGER S; BRUCKERT E; TURPIN G
      LIPID RISK-FACTORS OF ATHEROSCLEROSIS - WHO, WHEN AND HOW TO TREAT

      Annales d'Endocrinologie
    81. CHADAREVIAN R; BRUCKERT E; TURPIN G
      LIPID-LOWERING DRUGS AND PREVENTION OF CO RONARY HEART-DISEASE

      Annales de cardiologie et d'angeiologie
    82. MERZ CNB; ROZANSKI A; FORRESTER JS
      THE SECONDARY PREVENTION OF CORONARY-ARTERY DISEASE

      The American journal of medicine
    83. SNIDERMAN AD; PEDERSEN T; KJEKSHUS J
      PUTTING LOW-DENSITY LIPOPROTEINS AT CENTER STAGE IN ATHEROGENESIS

      The American journal of cardiology
    84. WEST MS; HERD JA; BALLANTYNE CM; POWNALL HJ; SIMPSON S; GOULD KL; GOTTO AM
      THE LIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY (LCAS) - DESIGN, METHODS, AND BASE-LINE DATA OF A TRIAL OF FLUVASTATIN IN PATIENTS WITHOUT SEVERE HYPERCHOLESTEROLEMIA

      Controlled clinical trials
    85. RACKLEY CE
      MONOTHERAPY WITH HMG-COA REDUCTASE INHIBITORS AND SECONDARY PREVENTION IN CORONARY-ARTERY DISEASE

      Clinical cardiology
    86. FRANKLIN BA; KAHN JK
      DELAYED PROGRESSION OR REGRESSION OF CORONARY ATHEROSCLEROSIS WITH INTENSIVE RISK FACTOR MODIFICATION - EFFECTS OF DIET, DRUGS, AND EXERCISE

      Sports medicine
    87. PUDDEY IB
      LOW SERUM-CHOLESTEROL AND THE RISK OF CEREBRAL-HEMORRHAGE

      Atherosclerosis
    88. LEE YJ; DAIDA H; YOKOI H; MIYANO H; TAKAYA J; SAKURAI H; MOKUNO H; YAMAGUCHI H
      EFFECTIVENESS OF PROBUCOL IN PREVENTING RESTENOSIS AFTER PERCUTANEOUSTRANSLUMINAL CORONARY ANGIOPLASTY

      Japanese Heart Journal
    89. LEWIS B
      CORONARY HEART-DISEASE PREVENTION AND THE INFARCTOGENIC PLAQUE

      Israel journal of medical sciences
    90. MARTINEZGONZALEZ J; BADIMON L
      HUMAN AND PORCINE SMOOTH-MUSCLE CELLS SHARE SIMILAR PROLIFERATION DEPENDENCE ON THE MEVALONATE PATHWAY - IMPLICATION FOR IN-VIVO INTERVENTIONS IN THE PORCINE MODEL

      European journal of clinical investigation
    91. MILLER BD; ALDERMAN EL; HASKELL WL; FAIR JM; KRAUSS RM
      PREDOMINANCE OF DENSE LOW-DENSITY-LIPOPROTEIN PARTICLES PREDICTS ANGIOGRAPHIC BENEFIT OF THERAPY IN THE STANFORD CORONARY RISK INTERVENTIONPROJECT

      Circulation
    92. ROHOLD A; HAASTRUP B; LARSEN S; HANSEN AB; LARSEN ML; HAGHFELT T
      DYSLIPIDEMIA AND CORONARY-ARTERY DISEASE - PREVALENCE AND TREATMENT IN PATIENTS REFERRED FOR CORONARY ARTERIOGRAPHY

      Cardiology
    93. VOGEL RA
      RISK FACTOR INTERVENTION AND CORONARY-ARTERY DISEASE - CLINICAL STRATEGIES

      Coronary artery disease
    94. JOST S; LICHTLEN PR
      TREATMENT OF ELEVATED CHOLESTEROL PLASMA- LEVELS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE

      Zeitschrift fur Kardiologie
    95. OKI JC
      DYSLIPIDEMIAS IN PATIENTS WITH DIABETES-MELLITUS - CLASSIFICATION ANDRISKS AND BENEFITS OF THERAPY

      Pharmacotherapy
    96. DIBIANCO R
      A REVIEW AND STRATEGY TO REDUCE THE MORBIDITY AND MORTALITY FROM CORONARY HEART-DISEASE - A PRACTICAL UPDATE AND GUIDE FOR PRIMARY-CARE PHYSICIANS

      South African medical journal
    97. BROSCHE T; SUMMA JD; KRAL C; PLATT D
      PHARMACOTHERAPEUTIC TREATMENT WITH LOVAST ATIN OF GERIATRIC-PATIENTS - EFFECTS ON ANTIOXIDANTS

      Die medizinische Welt
    98. PAZZUCCONI F; DORIGOTTI F; GIANFRANCESCHI G; CAMPAGNOLI G; SIRTORI M; FRANCESCHINI G; SIRTORI CR
      THERAPY WITH HMG COA REDUCTASE INHIBITORS - CHARACTERISTICS OF THE LONG-TERM PERMANENCE OF HYPOCHOLESTEROLEMIC ACTIVITY

      Atherosclerosis
    99. ROBERTS WC
      PREVENTING AND ARRESTING CORONARY ATHERSCLEROSIS

      The American heart journal
    100. SCHMITZ G; LACKNER KJ
      LIPID-LOWERING THERAPY - IMPLICATIONS FOR THE PREVENTION OF ATHEROSCLEROSIS

      Basic research in cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 03:40:40